- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Biomolecules, Volume 12, Issue 8
August 2022 - 152 articles
Cover Story: More than two years after the appearance of SARS-CoV-2, COVID-19 is still a public health emergency. Thus, the need to develop new active therapies based on nanomaterials but also derived from natural matrices is evident. Herein, we have reviewed the most innovative nanomaterials that show potential for use as therapeutic agents as well as measures to control virus spread. Furthermore, the review shows how computer-aided technologies can identify, in a rapid and constantly updated way, plant drugs potentially able to inhibit SARS-CoV-2 cell penetration. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

